| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| streptokinas 1,5 miljoner IE, pulver till infusionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| streptokinas 250 000 IE, pulver till infusionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| streptokinas 750000 IE, pulver till infusionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| cefotaxim 2 g, pulver till infusionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| imipenem 500 mg/cilastatin 500 mg, pulver till injektionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| amfotericin 100 mg, pulver till infusionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| cisplatin 50 mg, pulver till infusionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| vankomycinhydroklorid 10 g, pulver till infusionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| erytromycinlaktobionat 500 mg, pulver till infusionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| erytromycinlaktobionat 1 g, pulver till infusionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Drotrecogin alfa 5 mg powder for solution for injection vial |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| drotrecogin alfa 20 mg, pulver till infusionsväska, lösning, flaska |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| ertapenem 1 g, pulver till infusionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| drotrecogin alfa (aktiverat) 5 mg, pulver till infusionsvätska, lösning, flaska |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| vankomycinhydroklorid 750 mg, pulver till infusionsvätska, lösning |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| gemcitabin 2 g, pulver till infusionsvätska, lösning |
Has manufactured dose form |
False |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Trastuzumab emtansine 100 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Lyophilized powder for solution for infusion |
Is a |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely aciclovir (as aciclovir sodium) 250 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Blinatumomab 38.5 microgram powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely belatacept 250 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely bendamustine hydrochloride 25 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely rabbit anti-human T-lymphocyte globulin 25 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely anidulafungin 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely alglucosidase alfa 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely carfilzomib 60 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely carfilzomib 10 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely carfilzomib 30 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Dacarbazine (as dacarbazine citrate) 1 g powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely dacarbazine (as dacarbazine citrate) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Dexrazoxane (as dexrazoxane hydrochloride) 500 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Decitabine 50 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Clarithromycin (as clarithromycin lactobionate) 500 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely fosfomycin (as fosfomycin sodium) 4 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Fosfomycin (as fosfomycin sodium) 2 g powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Fosaprepitant (as fosaprepitant dimeglumine) 150 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely hydroxocobalamin 2.5 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Voriconazole 200 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely verteporfin 15 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely vancomycin (as vancomycin hydrochloride) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Vancomycin (as vancomycin hydrochloride) 500 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Powder for conventional release solution for infusion or injection (dose form) |
Is a |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely ceftaroline fosamil (as ceftaroline fosamil acetic acid solvate) 600 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Caspofungin (as caspofungin acetate) 50 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely caspofungin (as caspofungin acetate) 70 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely delafloxacin (as delafloxacin meglumine) 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Carmustine 100 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely infliximab 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely inotuzumab ozogamicin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely ganciclovir (as ganciclovir sodium) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Gemtuzumab ozogamicin 5 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Melphalan (as melphalan hydrochloride) 50 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely normal human immunoglobulin 10 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Topotecan (as topotecan hydrochloride) 1 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Tigecycline 50 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely thiotepa 15 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely thiotepa 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Thiotepa 400 mg powder for solution for infusion bag |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Tasonermin 1 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Siltuximab 100 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Vedolizumab 300 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Trabectedin 1 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely trastuzumab 420 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Trastuzumab 60 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Trabectedin 250 microgram powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Trastuzumab deruxtecan 100 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely pemetrexed (as pemetrexed disodium) 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Pemetrexed (as pemetrexed disodium) 500 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Rasburicase 1.5 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely velaglucerase alfa 400 unit/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Isavuconazole (as isavuconazonium sulfate) 200 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Lenograstim 33.6 million unit powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely remifentanil (as remifentanil hydrochloride) 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely remifentanil (as remifentanil hydrochloride) 2 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely remifentanil (as remifentanil hydrochloride) 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Cefalotin (as cefalotin sodium) 2 g powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely ceftriaxone (as ceftriaxone sodium) 2 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Daptomycin 500 mg powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely cloxacillin (as cloxacillin sodium) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Cloxacillin (as cloxacillin sodium) 2 g powder for solution for infusion vial |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
| Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has manufactured dose form |
True |
Powder for conventional release solution for infusion (dose form) |
Inferred relationship |
Some |
|
FHIR